person · Reporting owner
Agwunobi, M.D. Andrew C.
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
HUMANA INC
Report date April 01, 2023 · Filed April 03, 2023
Section 16 reporting ended · disclosed 2023-04-03. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Humana CommonSEC Table I · non-derivative | Direct | 182 |
Reported balance
Holding disclosure · report date 2023-04-01 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 182 |
| OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $430.62 · Expires 2029-03-01 | Direct | 3,086 |
Reported balance
Holding disclosure · report date 2023-04-01 · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · Balance 3,086 F1: Right to buy pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 3/1/2022, vesting in three annual increments from 3/1/23 to 3/1/25. |
| OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $510.24 · Expires 2030-02-24 | Direct | 2,838 |
Reported balance
Holding disclosure · report date 2023-04-01 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance 2,838 F2: Right to buy pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 2/24/2023, vesting in three annual increments from 2/24/24 to 2/24/26. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 523 |
Reported balance
Holding disclosure · report date 2023-04-01 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 523 F3: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F4: Restricted stock units granted to reporting person on 3/1/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 735 |
Reported balance
Holding disclosure · report date 2023-04-01 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 735 F3: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F5: Restricted stock units granted to reporting person on 2/24/2023, 33% of the award is vesting on 12/15/23, 12/15/24, and 12/15/25. |
Filing footnotes · ownership attribution and instrument terms
F1: Right to buy pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 3/1/2022, vesting in three annual increments from 3/1/23 to 3/1/25.
F2: Right to buy pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 2/24/2023, vesting in three annual increments from 2/24/24 to 2/24/26.
F3: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).
F4: Restricted stock units granted to reporting person on 3/1/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24.
F5: Restricted stock units granted to reporting person on 2/24/2023, 33% of the award is vesting on 12/15/23, 12/15/24, and 12/15/25.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 24, 2023 Filed Feb 28, 2023 15:27 UTC | HUMANA INC HUM · Entity 1429 | GrantRestricted Stock Units · Derivative | 735 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-005046 · form4.xml · derivative · entry 5 Agwunobi, M.D. Andrew C. · CIK 0001365029 · Seg. President, Home Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 735 Underlying: Humana Common · 735 shares Expires not disclosed F3 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F3 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F5 · derivative.exercise_date: Restricted stock units granted to reporting person on 2/24/2023, 33% of the award is vesting on 12/15/23, 12/15/24, and 12/15/25. F5 · derivative.expiration_date: Restricted stock units granted to reporting person on 2/24/2023, 33% of the award is vesting on 12/15/23, 12/15/24, and 12/15/25. Read SEC document |
| February 24, 2023 Filed Feb 28, 2023 15:27 UTC | HUMANA INC HUM · Entity 1429 | GrantOptions · Derivative | 2,838 | $0.00 Strike: $510.24 | $0.00 |
DisclosureSEC source: 0001062993-23-005046 · form4.xml · derivative · entry 3 Agwunobi, M.D. Andrew C. · CIK 0001365029 · Seg. President, Home Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,838 Underlying: Humana Common · 2,838 shares Expires 2030-02-24 F2 · security: Right to buy pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 2/24/2023, vesting in three annual increments from 2/24/24 to 2/24/26. F2 · derivative.exercise_date: Right to buy pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 2/24/2023, vesting in three annual increments from 2/24/24 to 2/24/26. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 18:03 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionRestricted Stock Units · Derivative | 261 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-024063 · form4.xml · derivative · entry 4 Agwunobi, M.D. Andrew C. · CIK 0001365029 · Seg. President, Home Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 523 Underlying: Humana Common · 261 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F2 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F3 · derivative.exercise_date: Restricted stock units granted to reporting person on 3/1/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24. F3 · derivative.expiration_date: Restricted stock units granted to reporting person on 3/1/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 18:03 UTC | HUMANA INC HUM · Entity 1429 | Tax withholdingHumana Common | 79 | $510.02 | $40,291.58 |
DisclosureSEC source: 0001062993-22-024063 · form4.xml · nonDerivative · entry 2 Agwunobi, M.D. Andrew C. · CIK 0001365029 · Seg. President, Home Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 182 F4 · shares: Disposition reported represents shares withheld for payment of tax liability associated with vesting of Restricted Stock Units on 12/15/22. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 18:03 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionHumana Common | 261 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-024063 · form4.xml · nonDerivative · entry 1 Agwunobi, M.D. Andrew C. · CIK 0001365029 · Seg. President, Home Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 261 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 16:30 UTC | HUMANA INC HUM · Entity 1429 | GrantRestricted Stock Units · Derivative | 784 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-006530 · form4.xml · derivative · entry 3 Agwunobi, M.D. Andrew C. · CIK 0001365029 · Seg. President, Home Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 784 Underlying: Humana Common · 784 shares Expires not disclosed F2 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F2 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F3 · derivative.exercise_date: Restricted stock units granted to reporting person on 3/1/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24. F3 · derivative.expiration_date: Restricted stock units granted to reporting person on 3/1/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 16:30 UTC | HUMANA INC HUM · Entity 1429 | GrantOptions · Derivative | 3,086 | $0.00 Strike: $430.62 | $0.00 |
DisclosureSEC source: 0001062993-22-006530 · form4.xml · derivative · entry 2 Agwunobi, M.D. Andrew C. · CIK 0001365029 · Seg. President, Home Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,086 Underlying: Humana Common · 3,086 shares Expires 2029-03-01 F1 · security: Right to buy pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 3/1/2022, vesting in three annual increments from 3/1/23 to 3/1/25. F1 · derivative.exercise_date: Right to buy pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 3/1/2022, vesting in three annual increments from 3/1/23 to 3/1/25. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.